Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-13 4:30 pm Purchase | 2025-03-31 | 13G | Fulgent Genetics, Inc. FLGT | BARCLAYS PLC | 2,338,451 7.570% | 680,392 (+41.04%) | Filing History |
| 2025-05-06 4:04 pm Purchase | 2025-03-31 | 13G | Fulgent Genetics, Inc. FLGT | Integrated Core Strategies (US) LLC | 1,969,433 6.500% | 438,787 (+28.67%) | Filing History |
| 2025-04-03 4:17 pm Sale | 2025-03-31 | 13G | Fulgent Genetics, Inc. FLGT | BlackRock Inc. BLK | 1,819,823 5.900% | -1,942,055 (-51.62%) | Filing History |
| 2025-03-21 4:52 pm Unchanged | 2024-12-31 | 13G | Fulgent Genetics, Inc. FLGT | BARCLAYS PLC | 1,658,059 5.420% | 0 (Unchanged) | Filing History |
| 2025-02-07 4:34 pm Purchase | 2024-12-31 | 13G | Fulgent Genetics, Inc. FLGT | BARCLAYS PLC | 1,658,059 5.420% | 1,658,059 (New Position) | Filing History |
| 2025-01-08 4:00 pm Purchase | 2024-12-31 | 13G | Fulgent Genetics, Inc. FLGT | Integrated Core Strategies (US) LLC | 1,530,646 5.000% | 1,530,646 (New Position) | Filing History |
| 2024-11-05 4:46 pm Purchase | 2024-11-01 | 13D | Fulgent Genetics, Inc. FLGT | Hsieh Ming | 8,730,670 28.500% | 46,568 (+0.54%) | Filing History |
| 2024-01-23 4:13 pm Purchase | 2023-12-31 | 13G | Fulgent Genetics, Inc. FLGT | BlackRock Inc. BLK | 3,761,878 12.700% | 234,096 (+6.64%) | Filing History |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Fulgent Genetics, Inc. FLGT | BlackRock Inc. BLK | 3,527,782 12.000% | 0 (Unchanged) | Filing History |
| 2023-01-20 3:00 pm Purchase | 2022-12-31 | 13G | Fulgent Genetics, Inc. FLGT | BlackRock Inc. BLK | 3,527,782 12.000% | 106,531 (+3.11%) | Filing History |
| 2022-11-09 9:38 pm Purchase | 2022-11-07 | 13D | Fulgent Genetics, Inc. FLGT | Hsieh Ming | 8,684,102 29.500% | 923,369 (+11.90%) | Filing History |
| 2022-01-27 5:14 pm Unchanged | 2021-12-31 | 13G | Fulgent Genetics, Inc. FLGT | BlackRock Inc. BLK | 3,421,251 11.500% | 0 (Unchanged) | Filing History |
| 2022-01-26 09:16 am Purchase | 2021-12-31 | 13G | Fulgent Genetics, Inc. FLGT | BlackRock Inc. BLK | 3,421,251 11.500% | 363,936 (+11.90%) | Filing History |
| 2021-07-12 08:29 am Purchase | 2021-06-30 | 13G | Fulgent Genetics, Inc. FLGT | BlackRock Inc. BLK | 3,057,315 10.500% | 1,072,448 (+54.03%) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Fulgent Genetics, Inc. FLGT | BlackRock Inc. BLK | 1,984,867 8.200% | 1,984,867 (New Position) | Filing History |
| 2020-12-22 5:06 pm Purchase | 2020-12-15 | 13D | Fulgent Genetics, Inc. FLGT | Ming Hsieh Trust | 7,897,115 32.500% | 7,897,115 (New Position) | Filing History |
| 2020-09-17 4:11 pm Sale | 2020-09-15 | 13D | Fulgent Genetics, Inc. FLGT | Gao Hanlin | 803,379 3.600% | -964,280 (-54.55%) | Filing History |